Cannabis and Hemp Industry Investment News
Building on Embark’s strength in innovation and creating industry-leading Cannabis 2.0 products, it recently announced new product offerings through i...
It is the first of three clinical trials aimed at assessing this potential treatment, and dosing of human volunteers has begun The first trial is a ra...
Embark continues to work toward a public listing in 2021 after deciding to pursue a direct listing of Mesa Exploration on March 11. Embark Health is a...
The firm said the collaboration will result in expanded capacity and product lines at Copperstate’s facilities to service growing Arizona cannabis dem...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Fidelity Minerals Corp ( ) (OTC:SAIDF) (FRA:S5...
Lexaria provided Amari with its DehydraTECH technology, which delivers CBD to the body more quickly and effectively than traditional formulations Hund...
The amended sales license will allow the company to sell dried cannabis products, including flower and pre-rolls, directly to the provincial and terri...
The supply agreements with CannTx Life Sciences Inc, Rilaxe Canna Inc, and Safari Flower Co will expand CannMart’s product offerings to its recreation...
Dyck has a wealth of experience leading cannabis-related medical research and has deep connections and a high standing throughout the industry, the co...
The THC Testkit was developed and produced by Farmako in-house as a tool for pharmacists to detect THC and identify medical cannabis flowers and extra...
MMJ continues to see an industry that is still in its growth phase but maturing in terms of management competence and capital structures employed. MMJ...
Heritage Cannabis (CSE: CANN- OTCQX: HERTF) CEO Clint Sharples joined Steve Darling from Proactive to share details the company has expanded its relat...
CEO Elise Coppens said AgraFlora is in “the best financial shape that it has been in over 24 months” after the sale of EIC and AAA Heidelberg Coppens ...
Heritage Cannabis shareholder Merida Capital will help introduce Heritage’s brands and products into select states, where medical and/or recreational ...
The new study programs will target NSAIDs, nicotine replacement therapies, tetrahydrocannabinol (THC), and erectile dysfunction Each study will evalu...
